Chinese Biotech Company Censured for Claiming It Could Make Experimental Coronavirus Drug
in the race to find a treatment for the virus that’s now sickened over 88,000 and killed over 3,000.
BrightGene also has not been licensed by the patent owner — Gilead — to make the drug, nor has it obtained “the relevant qualifications” for mass production of the therapy, said the stock exchange. Shares fell by the daily limit of 20% intraday on Monday. Gilead’s experimental drug, which has not been licensed or approved for use anywhere in the world, is being tested in clinical trials at hospitals in the central Chinese city of Wuhan, the epicenter of the coronavirus outbreak, as well as in other Asian nations.on Feb. 12 that it had managed to manufacture remdesivir in mass quantities garnered global headlines and sent its stock up nearly 60% last month to touch a record high.
BrightGene, for example, had only been able to make remdesivir in a small quantity for clinical research and not commercial production and its elision of this difference led to the spread of “unclear, inaccurate information,”BrightGene’s board secretary Wang Zhengye, who gave interviews to local media outlets saying the company’s drug is not for just for laboratory use but for mass production, was alsoWith the virus now being reported in over 65 countries, exuberance among investors and medical...
The design and execution of some of these trials have raised concerns among scientists, according to an
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wuhan closes makeshift hospital as new coronavirus cases in China drop sharplyThe Chinese city at the center of the coronavirus epidemic closed its first make...
Read more »
EU's Breton: Coronavirus costs €1 billion per month to European tourismThe coronavirus outbreak, which is grounding Chinese tourists, is costing the Eu...
Read more »
New York Times warns it's seeing a slowdown in ad bookings due to coronavirus fearsThe New York Times company says it's seeing a slowdown in advertising bookings that it's associating with 'uncertainty and anxiety' around the coronavirus.
Read more »
Breakingviews - Virus could give dealmakers a new big MAC attack(Reuters Breakingviews) - The coronavirus is making dealmakers a little queasy. ...
Read more »
News Corp, owner of Wall Street Journal, halts nonessential travel for employees due to coronavirusThe New York-based media company, which owns The Wall Street Journal and HarperCollins Publishers, joins a growing list of U.S. companies that are restricting employee travel as the coronavirus intensifies.
Read more »
First U.S. coronavirus death confirmed in Washington state, Mike Pence announces new travel restrictions on IranSeveral Washington state health agencies confirmed Saturday afternoon that the country's first coronavirus death occurred and that multiple new cases of coronavirus have been detected in the region.
Read more »